{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:18:06Z","timestamp":1790716686845,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ophtha.2007.03.074","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T18:07:41Z","timestamp":1183658861000},"page":"1378-1383","source":"Crossref","is-referenced-by-count":175,"title":["Secondary Acute Myelogenous Leukemia in Patients with Retinoblastoma"],"prefix":"10.1016","volume":"114","author":[{"given":"Dan S.","family":"Gombos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hungerford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Chantada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira J.","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia B.G.","family":"Antoneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Greenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barret G.","family":"Haik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Medina-Sanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Schefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavivann","family":"Veerakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Bornfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Bing On","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2007.03.074_bib1","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archopht.1996.01100140548005","article-title":"Chemotherapy plus local treatment in the management of intraocular retinoblastoma","volume":"114","author":"Murphree","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archopht.1996.01100140539004","article-title":"Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma","volume":"114","author":"Kingston","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/archopht.1996.01100140530002","article-title":"Chemoreduction in the initial management of intraocular retinoblastoma","volume":"114","author":"Shields","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib4","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0161-6420(97)30053-0","article-title":"Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma","volume":"104","author":"Shields","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.074_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bjo.86.1.80","article-title":"Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location and age","volume":"86","author":"Gombos","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0161-6420(02)01053-9","article-title":"Chemothermotherapy in the management of retinoblastoma","volume":"109","author":"Lumbroso","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.074_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/bjo.87.1.90","article-title":"Thermochemotherapy in hereditary retinoblastoma","volume":"87","author":"Schueler","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00055735-200310000-00010","article-title":"Emerging strategies for the treatment of retinoblastoma","volume":"14","author":"Deegan","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib9","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0161-6420(84)34127-6","article-title":"Second nonocular tumors in retinoblastoma survivors: are they radiation-induced?","volume":"91","author":"Abramson","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.074_bib10","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(01)00713-8","article-title":"Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma","volume":"108","author":"Abramson","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.074_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0161-6420(98)94006-4","article-title":"Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk","volume":"105","author":"Abramson","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.074_bib12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0161-6420(01)00562-0","article-title":"Second primary tumors in hereditary retinoblastoma: a register-based study, 1945\u20131997","volume":"108","author":"Moll","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.074_bib13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/jnci\/85.14.1121","article-title":"Mortality from second tumors among long-term survivors of retinoblastoma","volume":"85","author":"Eng","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2007.03.074_bib14","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","article-title":"Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up","volume":"23","author":"Kleinerman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mpo.1363","article-title":"Acute myeloid leukemia in a patient surviving retinoblastoma","volume":"38","author":"Gallegos-Castorena","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib16","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1200\/JCO.2001.19.21.4182","article-title":"Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma","volume":"19","author":"Nishimura","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1096-911X(199803)30:3<160::AID-MPO6>3.0.CO;2-F","article-title":"Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina","volume":"30","author":"Felice","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/bjc.1986.110","article-title":"Second primary neoplasms in patients with retinoblastoma","volume":"53","author":"Draper","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ophtha.2007.03.074_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/1097-0142(19850201)55:3<496::AID-CNCR2820550303>3.0.CO;2-U","article-title":"Acute non-lymphocytic leukemia following multimodality therapy for retinoblastoma","volume":"55","author":"White","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2007.03.074_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1399-0004.1995.tb03971.x","article-title":"Retinoblastoma in association with the chromosome breakage syndromes Fanconi\u2019s anaemia and Bloom\u2019s syndrome: clinical and cytogenetic findings","volume":"47","author":"Gibbons","year":"1995","journal-title":"Clin Genet"},{"key":"10.1016\/j.ophtha.2007.03.074_bib21","first-page":"65","article-title":"Secondary acute myeloid leukemia after therapy for extraocular retinoblastoma: a case report","volume":"2","author":"Antoneli","year":"1998","journal-title":"South Am J Cancer"},{"key":"10.1016\/j.ophtha.2007.03.074_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1076\/opge.25.1.25.29003","article-title":"Lack of activity of oral etoposide for relapsed intraocular retinoblastoma","volume":"25","author":"Dunkel","year":"2004","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.ophtha.2007.03.074_bib23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archopht.119.9.1269","article-title":"Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma)","volume":"119","author":"Shields","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2007.03.074_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004320050156","article-title":"Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies","volume":"124","author":"Kollmannsberger","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.seminoncol.2003.08.022","article-title":"Second cancers after breast cancer treatment","volume":"30","author":"Matesich","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2003.03.114","article-title":"Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project experience","volume":"21","author":"Smith","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3816\/CBC.2003.n.032","article-title":"Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience","volume":"4","author":"Smith","year":"2003","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ophtha.2007.03.074_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0140-6736(91)90490-G","article-title":"Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin and bleomycin for germ-cell tumours","volume":"338","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2007.03.074_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mpo.1125","article-title":"Leukemias related to treatment with DNA topoisomerase II inhibitors","volume":"36","author":"Felix","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib31","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.1998.16.10.3386","article-title":"Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors","volume":"16","author":"Kollmannsberger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mpo.1126","article-title":"Therapy-related leukemia associated with alkylating agents","volume":"36","author":"Davies","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.1993.11.2.209","article-title":"Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide","volume":"11","author":"Winick","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mpo.2950230205","article-title":"Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks","volume":"23","author":"Smith","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/88.7.407","article-title":"The secondary leukemias: challenges and research directions","volume":"88","author":"Smith","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2007.03.074_bib36","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2007.03.074_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1999.17.2.569","article-title":"Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins","volume":"17","author":"Smith","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10428199809092683","article-title":"Expression of the retinoblastoma tumor suppressor gene (RBrb-1) in acute leukemia","volume":"28","author":"Sauerbrey","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ophtha.2007.03.074_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V91.1.231","article-title":"Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies","volume":"91","author":"La Starza","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2007.03.074_bib40","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V78.12.3259.3259","article-title":"Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia","volume":"78","author":"Ahuja","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2007.03.074_bib41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-2141.1996.d01-1804.x","article-title":"The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of diseases outcome","volume":"94","author":"Jamal","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ophtha.2007.03.074_bib42","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jama.278.15.1262","article-title":"Cancer incidence after retinoblastoma: radiation dose and sarcoma risk","volume":"278","author":"Wong","year":"1997","journal-title":"JAMA"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007003776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007003776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T02:14:15Z","timestamp":1587694455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007003776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0161642007003776"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.074","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}